$800,000 Available in Grants/Cooperative Agreements for Ovarian Cancer Proteogenomics Research
Grants
Copyright © Targeted News Service, 2020
Copyright © Targeted News Service, 2020
2020-04-04
by MYRA TUGADE
WASHINGTON, April 4 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to two grants or cooperative agreements for ovarian cancer proteogenomics research.
The estimated total program funding available was cited as $800,000. The category of funding activity is science and technology and other research and development.
The agency description of the grant/cooperative agreement states: "The OCRP Proteogenomics Research Award support . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, April 4 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to two grants or cooperative agreements for ovarian cancer proteogenomics research.
The estimated total program funding available was cited as $800,000. The category of funding activity is science and technology and other research and development.
The agency description of the grant/cooperative agreement states: "The OCRP Proteogenomics Research Award support . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com